RBV Capital

What is RBV Capital?

RBV Capital is a venture capital firm based in Moscow, Russia, specializing in investments within the life sciences sector. Established in 2014, the fund focuses on early to market stage companies at the nexus of biological, chemical, engineering, and information technologies.

They primarily target ventures in the fields of biopharmaceuticals, biomedical technology, services, bioinformatics, healthcare technology, medical devices, and innovative healthcare providers, as well as enterprises that bridge multiple disciplines. The firm operates with a clear investment thesis that values the convergence and intersection of various scientific and technological fields to foster groundbreaking advancements in the life sciences industry. As a dedicated life sciences venture capital fund, RBV Capital has built a portfolio of innovative biomedical projects that reflect their specialized expertise in equity and their commitment to fostering early-stage development.

The fund completed its investment cycle in 2020 and is currently focusing on the divestment stage of its operations. Their approach involves providing not only capital but also strategic guidance to transformative companies that aim to revolutionize healthcare and improve patient outcomes through technological and scientific innovation.

RBV Capital leverages its experience and network within the life sciences sector in Russia and beyond to ensure the sustained growth and scaling of their portfolio companies.